Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

Clinical trial NCT04541225 · TERMINATED

Trial details

NCT number: NCT04541225
Sponsor: Nuvation Bio Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioma Glioma, Malignant Glioma, Mixed Glial Cell Tumors Breast Cancer Breast Carcinoma Cancer of Breast Cancer of the Breast Breast Tumor Malignant Tumor of Breast Advanced Breast Cancer Advanced Breast Carcinoma

Start date: 2020-12-08
Primary completion: 2022-08-31
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.